Quanterix (QTRX) Common Equity (2017 - 2026)
Quanterix (QTRX) posted Common Equity of $282.1 million for Q1 2026, down 4.6% on a QoQ basis from $295.7 million in Q4 2025, and down 10.83% year-over-year from $316.4 million in Q1 2025.
Quanterix (QTRX) Common Equity (2017 - 2026) Analysis & Trends
Quanterix's Common Equity history runs 10 years deep, the most recent figure standing at $282.1 million for Q1 2026.
- Quarterly Common Equity fell 10.83% year-over-year to $282.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $282.1 million (down 10.83% YoY) and the FY2025 annual result came in at $295.7 million, down 10.4% from the prior year.
- Common Equity was $282.1 million for Q1 2026 at Quanterix, down from $295.7 million in the prior quarter.
- Across five years, Common Equity topped out at $428.5 million in Q1 2022 and bottomed at $282.1 million in Q1 2026.
- A 5-year average of $342.9 million and a median of $343.4 million in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity dropped 19.16% — and 2023, when it fell 2.23%.
- Quanterix's Common Equity stood at $357.9 million in 2022, then decreased by 2.23% to $350.0 million in 2023, then decreased by 5.69% to $330.0 million in 2024, then decreased by 10.4% to $295.7 million in 2025, then slipped by 4.6% to $282.1 million in 2026.
- Business Quant data shows QTRX's Common Equity at $282.1 million in Q1 2026, $295.7 million in Q4 2025, and $314.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 38.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.86 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.96 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 13.34 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.29 Bn |
| 10 | Quanterix | 184.16 Mn | 84.89 Mn | 15.57 Mn | 282.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 282.14 Mn |
| Dec 31, 2025 | 295.73 Mn |
| Sep 30, 2025 | 314.53 Mn |
| Jun 30, 2025 | 292.46 Mn |
| Mar 31, 2025 | 316.39 Mn |
| Dec 31, 2024 | 330.04 Mn |
| Sep 30, 2024 | 338.88 Mn |
| Jun 30, 2024 | 340.78 Mn |
| Mar 31, 2024 | 343.38 Mn |
| Dec 31, 2023 | 349.96 Mn |
| Sep 30, 2023 | 352.79 Mn |
| Jun 30, 2023 | 353.75 Mn |
| Mar 31, 2023 | 355.19 Mn |
| Dec 31, 2022 | 357.93 Mn |
| Sep 30, 2022 | 371.29 Mn |
| Jun 30, 2022 | 405.47 Mn |
| Mar 31, 2022 | 428.46 Mn |
| Dec 31, 2021 | 442.79 Mn |
| Sep 30, 2021 | 455.51 Mn |
| Jun 30, 2021 | 466.01 Mn |